Stanley Druckenmiller acquired 2.38M Teva- Pharmaceutical Industries shares worth $74.8M. That's 2.32% of their equity portfolio (13th largest holding). The first Teva- Pharmaceutical Industries trade was made in Q4 2013. Since then Stanley Druckenmiller bought shares six more times and sold shares on four occasions. The stake costed the investor $42.7M, netting the investor a gain of 75% so far.